| PACKAGING TYPE: | 1.5gm C-box |
| COMPOSITION: | Ceftriaxone 1gm + Sulbactum 500 Mg |
| FORMULATION: | Injection |
| Description: | ALZICEF FORTE 1.5 gm Injection is a combination of Ceftriaxone (1 g) and Sulbactam (500 mg). It is a broad-spectrum antibiotic formulation designed to treat moderate to severe bacterial infections, including those caused by beta-lactamase producing resistant organisms. Ceftriaxone, a third-generation cephalosporin, inhibits bacterial cell wall synthesis, while Sulbactam enhances its efficacy by blocking beta-lactamase enzymes, thereby extending its antibacterial coverage. This combination is widely used in hospital and ICU settings for serious infections. |
| Side Effects: | Nausea or vomiting Diarrhea Injection site pain Rash or allergic reactions Rare liver enzyme elevation |
| How to Use: | To be administered by healthcare professionals only Given via IV or IM route as prescribed Dosage depends on infection severity and patient condition Reconstitute as per standard medical guidelines |
| Precaution: | For hospital use only Check for cephalosporin or penicillin allergy Use cautiously in liver and kidney impairment Avoid mixing with calcium-containing IV solutions Monitor liver function during prolonged therapy |
| Product Benefits: | Broad-spectrum antibacterial coverage Effective against resistant (beta-lactamase producing) bacteria Useful in moderate to severe infections Strong combination for hospital and ICU use Rapid bactericidal action Improves clinical outcomes in complica |
Frequently Asked Questions
It is used for moderate to severe bacterial infections, including resistant infections.
It prevents antibiotic resistance by inhibiting beta-lactamase enzymes.
Yes, it has extended coverage against resistant bacteria.


















